title: Targeting innate immunity: a new step in the development of combination therapy for chronic hepatitis B.
authors.forename: Fabien
authors.initials: F
authors.lastname: Zoulim
authors.forename: Souphalone
authors.initials: S
authors.lastname: Luangsay
authors.forename: David
authors.initials: D
authors.lastname: Durantel
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D006515:Hepatitis B virus / Q000187:drug effects*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D007155:Immunologic Factors / Q000627:therapeutic use*; D011621:Pteridines / Q000627:therapeutic use*; D051199:Toll-Like Receptor 7 / Q000819:agonists*; D019562:Viral Load / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D007155:Immunologic Factors; D011621:Pteridines; D051199:Toll-Like Receptor 7; C582524:vesatolimod